|
1
|
Liakou AI, Kontochristopoulos G, Agiasofitou E, Tsantes AG, Papadakis M, Marnelakis I, Tsante KA, Kapsiocha A, Katoulis A, Gregoriou S, Rigopoulos D. Colchicine Improves Clinical Outcomes and Quality of Life in Hidradenitis Suppurativa Patients: A Retrospective Study. J Clin Med 2021; 10:jcm10204742. [PMID: 34682864 PMCID: PMC8537423 DOI: 10.3390/jcm10204742] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Revised: 10/13/2021] [Accepted: 10/14/2021] [Indexed: 12/15/2022] Open
Abstract
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder of the follicular epithelium. The aim of the study was to investigate the effectiveness of colchicine on the clinical outcomes of HS patients, and to evaluate wither colchicine as monotherapy or in combination with doxycycline would provide better outcomes. Methods: A retrospective study was conducted including 44 patients with established HS, divided into three groups. The first group (n = 15 patients) received colchicine as monotherapy, the second group (n = 14 patients) received colchicine and doxycycline 100 mg/d, while the third group (n = 15 patients) received colchicine and doxycycline 40 mg/d. Disease severity during treatment was assessed at baseline and follow-up, using the Hurley Scoring System and the International Hidradenitis Suppurativa Severity Score System (IHS4). All patients were also asked to complete a Dermatology Life Quality Index (DLQI) questionnaire. These scores were compared among the study groups. Results: The DLQI and IHS4 scores significantly improved after treatment with colchicine (p < 0.001) in all groups. All colchicine regimes, including the single colchicine regime, colchicine plus doxycycline 100 mg regime, and colchicine plus doxycycline 40 mg regime, resulted in significant improvements in the DLQI and IHS4 scores (p < 0.001). Clinical improvement based on DLQI and IHS4 scores was similar in all groups. None of the patients had to discontinue the treatment due to adverse events. Discussion: In conclusion, our findings suggest that colchicine may improve clinical severity and quality of life in HS patients, either as monotherapy or in combination with doxycycline, both at antimicrobial (100 mg) and sub-antimicrobial (40 mg) doses.
Collapse
Affiliation(s)
- Aikaterini I. Liakou
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
- Correspondence: ; Tel.: +30-69-4535-3794
| | - Georgios Kontochristopoulos
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
| | - Efthymia Agiasofitou
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
| | - Andreas G. Tsantes
- Laboratory of Haematology and Blood Bank Unit, Faculty of Medicine, National and Kapodistrian University of Athens, “Attikon” General University Hospital, 12462 Athens, Greece; (A.G.T.); (K.A.T.)
| | - Marios Papadakis
- Department of Surgery II, University of Witten Herdecke, 58455 Wuppertal, Germany;
| | - Ioannis Marnelakis
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
| | - Konstantina A. Tsante
- Laboratory of Haematology and Blood Bank Unit, Faculty of Medicine, National and Kapodistrian University of Athens, “Attikon” General University Hospital, 12462 Athens, Greece; (A.G.T.); (K.A.T.)
| | - Anastasia Kapsiocha
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
| | - Alexandros Katoulis
- Second Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Attikon” General University Hospital, 12462 Athens, Greece;
| | - Stamatios Gregoriou
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
| | - Dimitris Rigopoulos
- First Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, 16121 Athens, Greece; (G.K.); (E.A.); (I.M.); (A.K.); (S.G.); (D.R.)
| |
Collapse
|
|
2
|
Host-Modulation Therapy and Chair-Side Diagnostics in the Treatment of Peri-Implantitis. BIOSENSORS-BASEL 2020; 10:bios10050044. [PMID: 32344881 PMCID: PMC7277891 DOI: 10.3390/bios10050044] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Revised: 04/22/2020] [Accepted: 04/24/2020] [Indexed: 12/17/2022]
Abstract
Previous studies report periodontitis and peri-implantitis being able to induce systemic low-grade inflammation, which is known to be associated with increased risk for some systemic medical disease such as cardiovascular disease. In this regard, recent studies have shown that host modulation therapy (HMT) together with traditional mechanical and surgical treatment not only cease the progression of periodontitis but also reduce the systemic collagenolytic biomarkers in both oral fluids and circulation. This suggests that the corresponding adjunctive HMT-medication could be effective in the prevention and treatment of dental peri-implantitis, as well. Furthermore, low-cost, safe, and practical oral fluid active matrix metalloproteinase-8 (aMMP-8) lateral-flow immunotests have been proposed as point-of-care/chair-side diagnostic tools to detect peri-implantitis and periodontitis, and to monitor their effective resolutions, while using various therapeutic strategies, including host modulation. This study reports the potential benefits of HMT-medication in the prevention and treatment of dental peri-implantitis among five patients (four of five were current/ex-smokers). In addition, the aMMP-8 point-of-care test diagnosed 20 peri-implantitis and 20 healthy controls correctly. In conclusion, this study and previous studies support the potential effectiveness of HMT-medication(s) and point-of-care/chair-side technologies in the treatment and diagnostics/monitoring of peri-implantitis. However, more studies are needed to further confirm this.
Collapse
|